Profiel
Louis R.
Bucalo was the founder of Titan Pharmaceuticals, Inc. which was founded in 1992, where he held the title of Executive Chairman in 2008.
Dr. Bucalo's former job was as an Associate Director-Clinical Research at Genentech, Inc. from 1990 to 1992.
Dr. Bucalo received his undergraduate degree from Harvard University and his doctorate degree from Stanford University.
Eerdere bekende functies van Louis Bucalo
| Bedrijven | Functie | Einde |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Algemeen Directeur | 01-10-2007 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-04-1992 |
Opleiding van Louis Bucalo
| Stanford University | Doctorate Degree |
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
